Neupril, a United States-based supplement company, announces serving over one million customers with its ...

Meesho IPO allotment will be finalised, and the company will now initiate refunds on Tuesday, December 9, while the shares ...

The shares of the company may become attractive to investors with a long-term thesis on consumption growth instead of a short ...

“This renewal of our validation is a significant achievement for GrowerIQ and our clients,” said Andrew Wilson, CEO of ...

Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...

Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares with no fresh issue component.

Senores Pharma receives Philippine FDA approval for 10 products: Our Bureau, Bengaluru Monday, December 8, 2025, 13:50 Hrs [IST] Senores Pharmaceuticals has received marketing aut ...

We interviewed doctors and experts to learn everything you need to know about the best NMN supplements for longevity, energy, and skin health ...

Anchor book bidding is scheduled for December 11, one day before the issue officially opens to the public. The IPO window ...

Retail investors led the demand, with their portion subscribed 11.46 times, while the non-institutional investor category was ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

All three issues are set to finalise allotments on December 8, 2025 and target a December 10, 2025 listing on both BSE and ...